138 related articles for article (PubMed ID: 3315587)
1. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study.
Monnier P; Sigwart U; Vincent A; Bachmann F; Goy JJ; Schaller MD; Kaufmann U; Badan M; Grbic M; Perret C
Drugs; 1987; 33 Suppl 3():175-8. PubMed ID: 3315587
[TBL] [Abstract][Full Text] [Related]
2. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
Brochier ML; Quilliet L; Kulbertus H; Materne P; Letac B; Cribier A; Monassier JP; Sacrez A; Favier JP
Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
Bonnier JJ
Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
[TBL] [Abstract][Full Text] [Related]
6. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
Anderson JL
Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584
[TBL] [Abstract][Full Text] [Related]
7. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
Kaspar L; Karnik R; Sehnal E; Zajicek P; Ziegler B; Slany J
Drugs; 1987; 33 Suppl 3():179-82. PubMed ID: 3315588
[TBL] [Abstract][Full Text] [Related]
9. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
[TBL] [Abstract][Full Text] [Related]
11. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
Johnson ES; Cregeen RJ
Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
[TBL] [Abstract][Full Text] [Related]
12. Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).
Taeymans Y; Materne P
Drugs; 1987; 33 Suppl 3():216-20. PubMed ID: 3315594
[TBL] [Abstract][Full Text] [Related]
13. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H
Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575
[TBL] [Abstract][Full Text] [Related]
14. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
[TBL] [Abstract][Full Text] [Related]
15. Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hillis WS; Hornung RS; Hogg KJ; Hockings N; Burns JM; Dunn FG
Drugs; 1987; 33 Suppl 3():117-23. PubMed ID: 3315576
[TBL] [Abstract][Full Text] [Related]
16. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study.
Timmis AD; Griffin B; Crick JC; Sowton E
J Am Coll Cardiol; 1987 Jul; 10(1):205-10. PubMed ID: 3298360
[TBL] [Abstract][Full Text] [Related]
17. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
Bassand JP; Machecourt J; Cassagnes J; Anguenot T; Lusson R; Borel E; Peycelon P; Wolf E; Ducellier D
J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
[TBL] [Abstract][Full Text] [Related]
18. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
Kasper W; Meinertz T; Wollschläger H; Bonzel T; Wolff P; Drexler H; Hofmann T; Zeiher A; Just H
Am J Cardiol; 1986 Sep; 58(6):418-21. PubMed ID: 3529908
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
Anderson JL
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy.
Marder VJ; Kinsella PA; Brown MJ
Drugs; 1987; 33 Suppl 3():237-41. PubMed ID: 3315601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
